Novavax (NVAX)
(Delayed Data from NSDQ)
$11.99 USD
+0.03 (0.25%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $11.96 -0.03 (-0.25%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Earnings News For NVAX
-
Novavax (NVAX) Lags on Q2 Earnings & Sales, Cuts '24 Outlook
-
Novavax (NVAX) Misses Q2 Earnings and Revenue Estimates
-
Novavax: Q2 Earnings Snapshot
-
Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights
-
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
-
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
-
Novavax: Q1 Earnings Snapshot
-
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
-
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
-
Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks
-
Novavax: Q4 Earnings Snapshot
-
Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates
-
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
Novavax (NVAX) Q4 Earnings Preview: What's in the Cards?
-
Novavax (NVAX) Beats on Q3 Earnings & Sales, Cuts Sales View
-
Novavax: Q3 Earnings Snapshot
-
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
-
Novavax (NVAX) Up 36.8% Since Last Earnings Report: Can It Continue?
-
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
-
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates
-
Novavax: Q2 Earnings Snapshot
-
Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights
-
Why Is Novavax (NVAX) Down 14.7% Since Last Earnings Report?
-
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View